Literature DB >> 14625142

Chronic electroconvulsive seizure up-regulates beta-catenin expression in rat hippocampus: role in adult neurogenesis.

Torsten M Madsen1, Samuel S Newton, Molly E Eaton, David S Russell, Ronald S Duman.   

Abstract

BACKGROUND: Beta-catenin was discovered as a cytoskeletal protein, constituting a link between the cadherins to the actin cytoskeleton. Aside from this function, beta-catenin is a key effector molecule in the Wnt signaling pathway, serving as a downstream transcription factor.
METHODS: In this study, we examined the influence of electroconvulsive seizures (ECS) on the expression of beta-catenin, as well as expression of Wnt-2, in rat hippocampus. Repeated administration of generalized seizures increased levels of beta-catenin immunoreactivity in the subgranular zone of the hippocampus. To assess the relationship of beta-catenin to cell division in the dentate gyrus of the adult rat hippocampus, colocalization of beta-catenin with a marker of cell division was examined.
RESULTS: Beta-catenin immunoreactivity was consistently localized in newborn cells in this region, indicating a possible role in cell division and differentiation in adult hippocampus. We also found that ECS treatment significantly increased levels of Wnt-2, one of the ligands that activates beta-catenin signaling.
CONCLUSIONS: These results demonstrate that ECS increases Wnt-beta-catenin signaling and suggest that this pathway could mediate in part the neuronal adaptations underlying the therapeutic action of this treatment paradigm.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14625142     DOI: 10.1016/s0006-3223(03)00700-5

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  44 in total

1.  Analysis of target genes regulated by chronic electroconvulsive therapy reveals role for Fzd6 in depression.

Authors:  Bhavya Voleti; Keith Q Tanis; Samuel S Newton; Ronald S Duman
Journal:  Biol Psychiatry       Date:  2011-09-19       Impact factor: 13.382

2.  The antidepressant-like effect of guanosine is dependent on GSK-3β inhibition and activation of MAPK/ERK and Nrf2/heme oxygenase-1 signaling pathways.

Authors:  Priscila B Rosa; Luis E B Bettio; Vivian B Neis; Morgana Moretti; Isabel Werle; Rodrigo B Leal; Ana Lúcia S Rodrigues
Journal:  Purinergic Signal       Date:  2019-11-25       Impact factor: 3.765

3.  Wnt2 regulates progenitor proliferation in the developing ventral midbrain.

Authors:  Kyle M Sousa; J Carlos Villaescusa; Lukas Cajanek; Jennifer K Ondr; Goncalo Castelo-Branco; Wytske Hofstra; Vitezslav Bryja; Carina Palmberg; Tomas Bergman; Brandon Wainwright; Richard A Lang; Ernest Arenas
Journal:  J Biol Chem       Date:  2009-12-16       Impact factor: 5.157

4.  Active Dentate Granule Cells Encode Experience to Promote the Addition of Adult-Born Hippocampal Neurons.

Authors:  Gregory W Kirschen; Jia Shen; Mu Tian; Bryce Schroeder; Jia Wang; Guoming Man; Song Wu; Shaoyu Ge
Journal:  J Neurosci       Date:  2017-04-03       Impact factor: 6.167

Review 5.  Pathogenesis of depression: Insights from human and rodent studies.

Authors:  C Ménard; G E Hodes; S J Russo
Journal:  Neuroscience       Date:  2015-05-30       Impact factor: 3.590

6.  Gadd45b Mediates Electroconvulsive Shock Induced Proliferation of Hippocampal Neural Stem Cells.

Authors:  Heechul Jun; Syed Mohammed Qasim Hussaini; Chang Hoon Cho; John Welby; Mi-Hyeon Jang
Journal:  Brain Stimul       Date:  2015-07-28       Impact factor: 8.955

7.  Experimental 'jet lag' inhibits adult neurogenesis and produces long-term cognitive deficits in female hamsters.

Authors:  Erin M Gibson; Connie Wang; Stephanie Tjho; Neera Khattar; Lance J Kriegsfeld
Journal:  PLoS One       Date:  2010-12-01       Impact factor: 3.240

8.  Epilepsy and the plastic mind.

Authors:  Janice Naegele
Journal:  Epilepsy Curr       Date:  2009 Nov-Dec       Impact factor: 7.500

9.  Generation and behavioral characterization of beta-catenin forebrain-specific conditional knock-out mice.

Authors:  Todd D Gould; Kelley C O'Donnell; Alyssa M Picchini; Eliot R Dow; Guang Chen; Husseini K Manji
Journal:  Behav Brain Res       Date:  2008-01-12       Impact factor: 3.332

Review 10.  GSK-3 is a viable potential target for therapeutic intervention in bipolar disorder.

Authors:  Michael K Rowe; Charlotte Wiest; De-Maw Chuang
Journal:  Neurosci Biobehav Rev       Date:  2007-03-15       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.